Allspring Global Investments
MIRM icon

Allspring Global Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

Allspring Global Investments’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Buy
2,552
+100
+4% +$10K ﹤0.01% 1570
2026
Q1 		$232K Buy
+2,452
New +$231K ﹤0.01% 1577
2025
Q2 		– Sell
-8,786
Closed -$396K – 1730
2025
Q1 		$396K Sell
8,786
-1,195
-12% -$56.3K ﹤0.01% 1520
2024
Q4 		$413K Buy
+9,981
New +$416K ﹤0.01% 1502
2024
Q2 		– Sell
-18,455
Closed -$464K – 2479
2024
Q1 		$464K Sell
18,455
-4,603
-20% -$127K ﹤0.01% 1548
2023
Q4 		$681K Buy
23,058
+25
+0.1% +$757 ﹤0.01% 1428
2023
Q3 		$728K Sell
23,033
-19,053
-45% -$522K ﹤0.01% 1440
2023
Q2 		$1.09M Buy
42,086
+5,657
+16% +$150K ﹤0.01% 1391
2023
Q1 		$875K Buy
36,429
+35,347
+3,267% +$806K ﹤0.01% 1452
2022
Q4 		$21.1K Sell
1,082
-24
-2% -$474 ﹤0.01% 2579
2022
Q3 		$23K Buy
+1,106
New +$26.6K ﹤0.01% 2591

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's MIRM Position: Q2 2026 in Review

Allspring Global Investments increased its Mirum Pharmaceuticals (MIRM) stake by 4.1% in Q2 2026, buying an estimated $10K and bringing the position to 2,552 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #1570.

Allspring Global Investments first reported a position in MIRM in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.09M in Q2 2023. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Allspring Global Investments held 2,552 shares of Mirum Pharmaceuticals worth $307K as of Q2 2026.
  • Allspring Global Investments bought 100 Mirum Pharmaceuticals shares in Q2 2026, an estimated $10K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1570 holding.
  • Allspring Global Investments first reported a position in Mirum Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
  • Allspring Global Investments's Mirum Pharmaceuticals position peaked at $1.09M in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.